Gainers

  • Emmaus Life Sciences, Inc. EMMA jumped 33.1% to $5.65.
  • SigmaTron International, Inc. SGMA shares climbed 22.6% to $3.2754 after the company reported Q4 results.
  • Huitao Technology Co. Ltd. HHT gained 21.6% to $4.4271.
  • Nuvectra Corporation NVTR rose 19.9% to $2.47.
  • Manhattan Associates, Inc. MANH gained 18.7% to $86.43 after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 EPS and sales guidance above analyst estimates.
  • Teradyne, Inc. TER shares climbed 18.4% to $56.95 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 EPS and sales guidance on the high end of analyst estimates.
  • Neuralstem, Inc. CUR gained 17% to $5.32.
  • Snap Inc. SNAP shares rose 15% to $17.06 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 sales guidance above analyst estimates and an increase in daily active users from Q2 last year.
  • Genomic Health, Inc. GHDX gained 13.8% to $64.58.
  • Constellium SE CSTM shares climbed 13.2% to $11.81.
  • Acasti Pharma Inc. . ACST rose 12.4% to $2.2815.
  • Integra LifeSciences Holdings Corporation IART climbed 12% to $62.11 following Q2 results.
  • Tenet Healthcare Corporation THC climbed 11.6% to $19.61.
  • Navient Corporation NAVI rose 11.2% to $15.23 after the company reported better-than-expected Q2 EPS results.
  • Lithia Motors, Inc. LAD climbed 11.2% to $131.49 following strong Q2 results.
  • M/I Homes, Inc. MHO rose 10.4% to $31.92 following upbeat Q2 earnings.
  • Jounce Therapeutics Inc JNCE shares gained 10% to $4.50 after the company announced an update on its strategic collaboration with Celgene.
  • Discover Financial Services DFS rose 8.7% to $91.80 after the company reported better-than-expected Q2 EPS and sales results.
  • Sprint Corporation S rose 8.4% to $7.68. Dish agreed to a $5 billion deal for wireless assets in deal with T-Mobile and Sprint, Bloomberg reported.
  • Edwards Lifesciences Corporation EW shares rose 8.2% to $211.57 after the company reported better-than-expected Q2 EPS and sales guidance. The company also raised FY19 EPS and sales guidance.
  • Xenetic Biosciences, Inc. XBIO shares rose 7.6% to $2.97 after dropping 17.86% on Tuesday.
  • Texas Instruments Incorporated TXN rose 7.5% to $129.03 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 sales guidance in-line with analyst estimates.
  • Chipotle Mexican Grill, Inc. CMG rose 5.4% to $779.41 after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 comps.


Check out these big penny stock gainers and losers

Losers

  • Healthcare Services Group, Inc. HCSG shares dipped 22.2% to $23.41 after reporting downbeat Q2 results.
  • CannTrust Holdings Inc. CTST fell 21.2% to $2.0650 after declining 4.03% on Tuesday.
  • iRobot Corporation IRBT dropped 18.2% to $73.29 after the company reported Q2 EPS and sales results down from last year. The company also issued FY19 sales guidance below analyst estimates.
  • Tupperware Brands Corporation TUP dropped 18.2% to $14.58 after the company reported downbeat Q2 results and lowered its guidance.
  • Therapix Biosciences Ltd. TRPX fell 16.2% to $2.85 after climbing 47.83% on Tuesday.
  • LSC Communications, Inc. LKSD dropped 16.2% to $1.92. Wells Fargo downgraded LSC Communications from Market Perform to Underperform.
  • Eagle Bulk Shipping Inc. EGLE fell 15.6% to $4.6350 after the company announced a $100 million offering of convertible senior notes due 2024.
  • Chiasma, Inc. CHMA dropped 15.2% to $6.67.
  • Calix, Inc. CALX declined 14.2% to $6.26 following Q2 results.
  • Golden Bull Limited DNJR dropped 11.4% to $1.87.
  • Fang Holdings Limited SFUN shares fell 10.8% to $2.31.
  • Rollins, Inc. ROL dropped 9.9% to $34.36 after the company reported worse-than-expected Q2 sales.
  • MarketAxess Holdings Inc. MKTX fell 9.3% to $333.50 following downbeat Q2 earnings.
  • Dynavax Technologies Corporation DVAX dropped 7.5% to $2.98.
  • Seattle Genetics, Inc. SGEN shares fell 5.6% to $71.67. Seattle Genetics priced 7.1 million share public offering of common stock at $70 per share.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs

Comments
Loading...